Treatment approaches in Gilles de la Tourette syndrome

Brain Research Bulletin

Volumn 11, Issue 2, 1983, Pages 205-208

  Borison, Richard L ^a   Ang, Lolita ^b   Hamilton, William J ^a   Diamond, Bruce I ^a   Davis, John M ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Amantadine; Clonidine Gilles de la Tourette syndrome; Haloperidol; Lithium

Indexed keywords

AMANTADINE; BENZATROPINE MESILATE; CLONIDINE; FLUPHENAZINE; HALOPERIDOL; LITHIUM CARBONATE; PLACEBO; TRIFLUOPERAZINE;

CASE REPORT; CENTRAL NERVOUS SYSTEM; DRUG ANTAGONISM; DRUG COMPARISON; DRUG THERAPY; EXTRAPYRAMIDAL SYMPTOM; GILLES DE LA TOURETTE SYNDROME; HUMAN; INTOXICATION; NERVOUS SYSTEM; NEUROTOXICITY; TARDIVE DYSKINESIA; THERAPY;

AMANTADINE; BENZTROPINE; CLONIDINE; FLUPHENAZINE; HALOPERIDOL; HUMANS; LITHIUM; TOURETTE SYNDROME; TRIFLUOPERAZINE;

EID: 0020526194     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/0361-9230(83)90192-2     Document Type: Article

References (6)

1. Clonidine ameliorates Gilles de la Tourette syndrome
2. Clonidine in Tourette's syndrome
3. Lithium therapy in Huntington's chorea and tardive dyskinesia
4. Lithium carbonate in Gilles de la Tourette's disease
5. Treatment of Tourette's syndrome